- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder Cancer Transitional Cell Carcinoma in Korea, Democratic People's Republic of
Total 1191 results
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Pusan National University Yangsan HospitalRecruitingUrothelial Carcinoma | Neoadjuvant Chemotherapy | Muscle Invasive Bladder CancerKorea, Republic of
-
Asan Medical CenterKorean Cancer Study GroupUnknownTransitional Cell Carcinoma | Bladder Cancer | Ureter Cancer | Urethral CancerKorea, Republic of
-
Five Prime Therapeutics, Inc.CompletedGastric Cancer | Advanced Solid Tumors | Transitional Cell Carcinoma of the BladderKorea, Republic of, United States, Taiwan
-
Asan Medical CenterKorean Cancer Study GroupUnknownTransitional Cell Carcinoma | Bladder Cancer | Ureter CancerKorea, Republic of
-
Asan Medical CenterCompletedUrothelial CarcinomaKorea, Republic of
-
Samsung Medical CenterActive, not recruitingUrothelial CarcinomaKorea, Republic of
-
Asan Medical CenterUnknownAdvanced Urothelial CarcinomaKorea, Republic of
-
Seoul National University HospitalUnknownUrothelial CarcinomaKorea, Republic of
-
Yonsei UniversityRecruitingProstate Cancer | Bladder Cancer | Renal Cell Cancer | Ureter CancerKorea, Republic of
-
Yonsei UniversityRecruitingProstate Cancer | Bladder Cancer | Renal Cell Cancer | Ureter Cancer | Urological MalignanciesKorea, Republic of
-
Yonsei UniversityNot yet recruitingMuscle-Invasive Bladder CarcinomaKorea, Republic of
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University Anam Hospital and other collaboratorsRecruitingUrothelial CarcinomaKorea, Republic of
-
Bristol-Myers SquibbPierre Fabre MedicamentCompletedKidney Neoplasms | Transitional Cell Carcinoma | Bladder Cancer | Bladder Neoplasms | Ureter Neoplasms | Neoplasm, BladderUnited States, Spain, Italy, Canada, Indonesia, Singapore, Australia, Austria, France, Greece, Korea, Republic of, Philippines, Sweden, Switzerland, Thailand
-
Hoffmann-La RocheGilead Sciences, Inc., GlaxoSmithKline plc, Seattle Genetics and AstellasRecruitingBladder Cancer | Urothelial CarcinomaUnited States, Spain, Korea, Republic of, United Kingdom, Taiwan, France, Greece
-
Yonsei UniversityUnknownHead Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell MetastaticKorea, Republic of
-
Yonsei UniversityCompletedHead Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell MetastaticKorea, Republic of
-
Bristol-Myers SquibbCompletedTransitional Cell Carcinoma | Bladder Cancer | MetastasisUnited States, Korea, Republic of, United Kingdom, Spain, Australia, France, Thailand, Denmark, Poland, Belgium, Italy, Philippines, Canada, Russian Federation, Greece, Indonesia
-
Samsung Medical CenterActive, not recruitingMuscle-Invasive Bladder Carcinoma | Radical Cystectomy | Multiparametric MRI | Vesical Imaging Report and Data SystemKorea, Republic of
-
Samyang Biopharmaceuticals CorporationTerminatedNon Muscle Invasive Bladder CancerKorea, Republic of
-
Yonsei UniversityCompletedProstate Cancer | Bladder CancerKorea, Republic of
-
Sung Yong OhUnknownMetastatic Cancer | Esophagus Squamous Cell Carcinoma (SCC)Korea, Republic of
-
Samsung Medical CenterUnknownBiliary Tract (Intrahepatic, Extrahepatic Cholangiocarcinoma, Gall Bladder) CancerKorea, Republic of
-
Yonsei UniversityCompletedNon -Small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityRecruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityNot yet recruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
Asan Medical CenterKorea Research Institute of Bioscience & BiotechnologyCompletedNon-small Cell Lung CancerKorea, Republic of
-
Asan Medical CenterEli Lilly and Company; Korean Cancer Study GroupUnknownNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterUnknownNon-small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterCompleted
-
Samsung Medical CenterAstraZenecaCompleted
-
Asan Medical CenterAstraZenecaUnknown
-
Gachon University Gil Medical CenterCompletedNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterUnknownNon-small Cell Lung CancerKorea, Republic of
-
Chonnam National University HospitalChong Kun Dang PharmaceuticalCompletedCarcinoma, Small CellKorea, Republic of
-
Yonsei UniversityNot yet recruiting
-
Yonsei UniversityRecruitingNon Small Cell Lung CancerKorea, Republic of
-
Asan Medical CenterAstraZenecaCompletedNon Small Cell Lung CancerKorea, Republic of
-
The Catholic University of KoreaUnknownNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterCompletedNon-small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityRecruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityRecruitingMuscle-invasive Bladder CancerKorea, Republic of
-
Seoul National University HospitalMACROGENUnknownNon Small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer RecurrentKorea, Republic of
-
Chonnam National University HospitalRoche Pharma AGCompletedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentKorea, Republic of